Medical device maker TaiDoc is optimistic about prospects in multifunctional personal physiological monitoring platforms amid ...

Women with gestational diabetes continue to have adverse pregnancy outcomes that are often related to hyperglycaemia.

Frequent use vs nonuse of a continuous glucose monitoring device is associated with improved long-term glycemic control in ...

Routine continuous glucose monitoring (CGM) use offers the greatest hemoglobin A1c reductions for patients with type 2 diabetes.

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose ...

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors ...

Dr. Casey Means & Dr. Andrew Huberman talk about the usage of CGM. Petition Forcing Epstein Vote Succeeds Over White House Objections ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and ...

Adults with type 2 diabetes who used a continuous glucose monitor and wore their sensor for more than 270 days in 1 year had ...

Dexcom has announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will launch in the United States on Dec. 1.

India lives with diabetes at a scale few nations do. More than 100 million adults are managing the condition, and many more remain undiagnosed until complications appear. For most families, glucose ...